Lataa...
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials
BACKGROUND: The use of auxiliary endpoints may provide efficiencies for clinical trial design, but such endpoints may not have intrinsic clinical relevance or clear linkage to more meaningful endpoints. The purpose of this study was to generate a novel endpoint that considers both overall survival (...
Tallennettuna:
| Julkaisussa: | Neuro Oncol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4490868/ https://ncbi.nlm.nih.gov/pubmed/25568226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou345 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|